Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal
The extra-hypothalamic actions of corticotropin-releasing hormone (CRH) have been accorded an important role in coordinating responses to stressors and contributing to the consequences of drug abuse. Recent proposals suggest that CRH actions in the bed nucleus of the stria terminalis coordinate resp...
Gespeichert in:
Veröffentlicht in: | Neuroscience 2002-01, Vol.112 (3), p.605-617 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 617 |
---|---|
container_issue | 3 |
container_start_page | 605 |
container_title | Neuroscience |
container_volume | 112 |
creator | McNally, G.P Akil, H |
description | The extra-hypothalamic actions of corticotropin-releasing hormone (CRH) have been accorded an important role in coordinating responses to stressors and contributing to the consequences of drug abuse. Recent proposals suggest that CRH actions in the bed nucleus of the stria terminalis coordinate responses to tonic/unpredictable stressors whereas these actions in the central nucleus of the amygdala coordinate responses to phasic/predictable stressors. We used
in situ hybridization histochemistry and site-specific microinjections of a CRH receptor antagonist to study the role of CRH in opiate withdrawal.
Rats undergoing opiate withdrawal displayed clear behavioral and autonomic changes accompanied by hyperalgesia and increased plasma corticosterone.
In situ hybridization of CRH mRNA revealed significant increases in the central nucleus of the amygdala but not in the bed nucleus of the stria terminalis among rats either chronically pre-treated with morphine, given an injection of naloxone, or both (precipitated withdrawal). An increase of CRH mRNA in the paraventricular nucleus of the hypothalamus was specific to rats undergoing withdrawal. Intracerebroventricular microinjection of the CRH receptor antagonist, αhCRH
9–41, reduced the severity of opiate withdrawal. Microinjections of αhCRH
9–41 into the central nucleus of the amygdala also reduced the severity of withdrawal whereas bed nucleus of the stria terminalis microinjections of αhCRH
9–41 were without effect.
These experiments provide evidence for a role of amygdala, but not bed nucleus of the stria terminalis, CRH in opiate dependence. We propose a specific role for down-regulation of opiate receptor signaling in increased expression of the CRH gene in the amygdala. Moreover, we suggest that the roles accorded to CRH in the bed nucleus of the stria terminalis versus amygdala in coordinating responses to stressors may need to be reconsidered to distinguish between external and internal/interoceptive stressors. |
doi_str_mv | 10.1016/S0306-4522(02)00105-7 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18473271</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0306452202001057</els_id><sourcerecordid>18473271</sourcerecordid><originalsourceid>FETCH-LOGICAL-c565t-a2091d0c5f6bf96cdf99f7601fd072678a5e855421697345bb55b83836ba63803</originalsourceid><addsrcrecordid>eNqFkd2KFDEQhRtR3HH1EZTcKArbmnQ6ne4rkcU_WBD8uQ7VSfVOJJ2MSXqXeS5f0PTM6F4aAoHKV6cOdarqKaOvGWXdm2-U065uRdO8pM0rShkVtbxXbVgveS1F296vNv-Qs-pRSj9pOaLlD6sz1lDZDrTZVL-_BockTESHmK0OOYad9XVEh5CsvybbEOfgkVhP8hYJzPtrAw4IeENGNMQv2uGSVon1P-VogWSMs_XgbPrbN-IWbmyI4C7IDkpxDmZxkEPcXxy00Jugoy2TdPAJfy3oNR5kiyHISG5t3poIt-AeVw8mcAmfnN7z6seH998vP9VXXz5-vnx3VWvRiVxDQwdmqBZTN05Dp800DJPsKJsMlU0nexDYC9E2rBskb8U4CjH2vOfdCB3vKT-vXhx1dzEUPymr2SaNzoHHsCTF-lbyRrICiiOoY0gp4qR20c4Q94pRtaalDmmpNQpFy13TUrL0PTsNWMYZzV3XKZ4CPD8BkDS4KYLXNt1xXHIp6VC4t0cOyzpuLEaVtF0XaGxEnZUJ9j9W_gBUPLRZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18473271</pqid></control><display><type>article</type><title>Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>McNally, G.P ; Akil, H</creator><creatorcontrib>McNally, G.P ; Akil, H</creatorcontrib><description>The extra-hypothalamic actions of corticotropin-releasing hormone (CRH) have been accorded an important role in coordinating responses to stressors and contributing to the consequences of drug abuse. Recent proposals suggest that CRH actions in the bed nucleus of the stria terminalis coordinate responses to tonic/unpredictable stressors whereas these actions in the central nucleus of the amygdala coordinate responses to phasic/predictable stressors. We used
in situ hybridization histochemistry and site-specific microinjections of a CRH receptor antagonist to study the role of CRH in opiate withdrawal.
Rats undergoing opiate withdrawal displayed clear behavioral and autonomic changes accompanied by hyperalgesia and increased plasma corticosterone.
In situ hybridization of CRH mRNA revealed significant increases in the central nucleus of the amygdala but not in the bed nucleus of the stria terminalis among rats either chronically pre-treated with morphine, given an injection of naloxone, or both (precipitated withdrawal). An increase of CRH mRNA in the paraventricular nucleus of the hypothalamus was specific to rats undergoing withdrawal. Intracerebroventricular microinjection of the CRH receptor antagonist, αhCRH
9–41, reduced the severity of opiate withdrawal. Microinjections of αhCRH
9–41 into the central nucleus of the amygdala also reduced the severity of withdrawal whereas bed nucleus of the stria terminalis microinjections of αhCRH
9–41 were without effect.
These experiments provide evidence for a role of amygdala, but not bed nucleus of the stria terminalis, CRH in opiate dependence. We propose a specific role for down-regulation of opiate receptor signaling in increased expression of the CRH gene in the amygdala. Moreover, we suggest that the roles accorded to CRH in the bed nucleus of the stria terminalis versus amygdala in coordinating responses to stressors may need to be reconsidered to distinguish between external and internal/interoceptive stressors.</description><identifier>ISSN: 0306-4522</identifier><identifier>EISSN: 1873-7544</identifier><identifier>DOI: 10.1016/S0306-4522(02)00105-7</identifier><identifier>PMID: 12074902</identifier><identifier>CODEN: NRSCDN</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Amygdala - physiopathology ; Animals ; anxiety ; Behavior, Animal - physiology ; Behavioral psychophysiology ; Biological and medical sciences ; Corticotropin-Releasing Hormone - administration & dosage ; Corticotropin-Releasing Hormone - genetics ; Corticotropin-Releasing Hormone - metabolism ; Corticotropin-Releasing Hormone - pharmacology ; drug dependence ; Endocrine Glands - physiopathology ; fear ; Fundamental and applied biological sciences. Psychology ; Hormones and behavior ; Humans ; hyperalgesia ; in situ hybridization ; Injections ; Injections, Intraventricular ; Male ; Morphine - adverse effects ; Naloxone - pharmacology ; Narcotic Antagonists - pharmacology ; Narcotics - adverse effects ; Pain - physiopathology ; Peptide Fragments - administration & dosage ; Peptide Fragments - pharmacology ; Psychology. Psychoanalysis. Psychiatry ; Psychology. Psychophysiology ; Rats ; Rats, Sprague-Dawley ; RNA, Messenger - metabolism ; Septal Nuclei - physiopathology ; stress ; Substance Withdrawal Syndrome - physiopathology ; Substance Withdrawal Syndrome - psychology</subject><ispartof>Neuroscience, 2002-01, Vol.112 (3), p.605-617</ispartof><rights>2002 IBRO</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c565t-a2091d0c5f6bf96cdf99f7601fd072678a5e855421697345bb55b83836ba63803</citedby><cites>FETCH-LOGICAL-c565t-a2091d0c5f6bf96cdf99f7601fd072678a5e855421697345bb55b83836ba63803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0306452202001057$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13737709$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12074902$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McNally, G.P</creatorcontrib><creatorcontrib>Akil, H</creatorcontrib><title>Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal</title><title>Neuroscience</title><addtitle>Neuroscience</addtitle><description>The extra-hypothalamic actions of corticotropin-releasing hormone (CRH) have been accorded an important role in coordinating responses to stressors and contributing to the consequences of drug abuse. Recent proposals suggest that CRH actions in the bed nucleus of the stria terminalis coordinate responses to tonic/unpredictable stressors whereas these actions in the central nucleus of the amygdala coordinate responses to phasic/predictable stressors. We used
in situ hybridization histochemistry and site-specific microinjections of a CRH receptor antagonist to study the role of CRH in opiate withdrawal.
Rats undergoing opiate withdrawal displayed clear behavioral and autonomic changes accompanied by hyperalgesia and increased plasma corticosterone.
In situ hybridization of CRH mRNA revealed significant increases in the central nucleus of the amygdala but not in the bed nucleus of the stria terminalis among rats either chronically pre-treated with morphine, given an injection of naloxone, or both (precipitated withdrawal). An increase of CRH mRNA in the paraventricular nucleus of the hypothalamus was specific to rats undergoing withdrawal. Intracerebroventricular microinjection of the CRH receptor antagonist, αhCRH
9–41, reduced the severity of opiate withdrawal. Microinjections of αhCRH
9–41 into the central nucleus of the amygdala also reduced the severity of withdrawal whereas bed nucleus of the stria terminalis microinjections of αhCRH
9–41 were without effect.
These experiments provide evidence for a role of amygdala, but not bed nucleus of the stria terminalis, CRH in opiate dependence. We propose a specific role for down-regulation of opiate receptor signaling in increased expression of the CRH gene in the amygdala. Moreover, we suggest that the roles accorded to CRH in the bed nucleus of the stria terminalis versus amygdala in coordinating responses to stressors may need to be reconsidered to distinguish between external and internal/interoceptive stressors.</description><subject>Amygdala - physiopathology</subject><subject>Animals</subject><subject>anxiety</subject><subject>Behavior, Animal - physiology</subject><subject>Behavioral psychophysiology</subject><subject>Biological and medical sciences</subject><subject>Corticotropin-Releasing Hormone - administration & dosage</subject><subject>Corticotropin-Releasing Hormone - genetics</subject><subject>Corticotropin-Releasing Hormone - metabolism</subject><subject>Corticotropin-Releasing Hormone - pharmacology</subject><subject>drug dependence</subject><subject>Endocrine Glands - physiopathology</subject><subject>fear</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hormones and behavior</subject><subject>Humans</subject><subject>hyperalgesia</subject><subject>in situ hybridization</subject><subject>Injections</subject><subject>Injections, Intraventricular</subject><subject>Male</subject><subject>Morphine - adverse effects</subject><subject>Naloxone - pharmacology</subject><subject>Narcotic Antagonists - pharmacology</subject><subject>Narcotics - adverse effects</subject><subject>Pain - physiopathology</subject><subject>Peptide Fragments - administration & dosage</subject><subject>Peptide Fragments - pharmacology</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychology. Psychophysiology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>RNA, Messenger - metabolism</subject><subject>Septal Nuclei - physiopathology</subject><subject>stress</subject><subject>Substance Withdrawal Syndrome - physiopathology</subject><subject>Substance Withdrawal Syndrome - psychology</subject><issn>0306-4522</issn><issn>1873-7544</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkd2KFDEQhRtR3HH1EZTcKArbmnQ6ne4rkcU_WBD8uQ7VSfVOJJ2MSXqXeS5f0PTM6F4aAoHKV6cOdarqKaOvGWXdm2-U065uRdO8pM0rShkVtbxXbVgveS1F296vNv-Qs-pRSj9pOaLlD6sz1lDZDrTZVL-_BockTESHmK0OOYad9XVEh5CsvybbEOfgkVhP8hYJzPtrAw4IeENGNMQv2uGSVon1P-VogWSMs_XgbPrbN-IWbmyI4C7IDkpxDmZxkEPcXxy00Jugoy2TdPAJfy3oNR5kiyHISG5t3poIt-AeVw8mcAmfnN7z6seH998vP9VXXz5-vnx3VWvRiVxDQwdmqBZTN05Dp800DJPsKJsMlU0nexDYC9E2rBskb8U4CjH2vOfdCB3vKT-vXhx1dzEUPymr2SaNzoHHsCTF-lbyRrICiiOoY0gp4qR20c4Q94pRtaalDmmpNQpFy13TUrL0PTsNWMYZzV3XKZ4CPD8BkDS4KYLXNt1xXHIp6VC4t0cOyzpuLEaVtF0XaGxEnZUJ9j9W_gBUPLRZ</recordid><startdate>20020101</startdate><enddate>20020101</enddate><creator>McNally, G.P</creator><creator>Akil, H</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope></search><sort><creationdate>20020101</creationdate><title>Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal</title><author>McNally, G.P ; Akil, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c565t-a2091d0c5f6bf96cdf99f7601fd072678a5e855421697345bb55b83836ba63803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Amygdala - physiopathology</topic><topic>Animals</topic><topic>anxiety</topic><topic>Behavior, Animal - physiology</topic><topic>Behavioral psychophysiology</topic><topic>Biological and medical sciences</topic><topic>Corticotropin-Releasing Hormone - administration & dosage</topic><topic>Corticotropin-Releasing Hormone - genetics</topic><topic>Corticotropin-Releasing Hormone - metabolism</topic><topic>Corticotropin-Releasing Hormone - pharmacology</topic><topic>drug dependence</topic><topic>Endocrine Glands - physiopathology</topic><topic>fear</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hormones and behavior</topic><topic>Humans</topic><topic>hyperalgesia</topic><topic>in situ hybridization</topic><topic>Injections</topic><topic>Injections, Intraventricular</topic><topic>Male</topic><topic>Morphine - adverse effects</topic><topic>Naloxone - pharmacology</topic><topic>Narcotic Antagonists - pharmacology</topic><topic>Narcotics - adverse effects</topic><topic>Pain - physiopathology</topic><topic>Peptide Fragments - administration & dosage</topic><topic>Peptide Fragments - pharmacology</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychology. Psychophysiology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>RNA, Messenger - metabolism</topic><topic>Septal Nuclei - physiopathology</topic><topic>stress</topic><topic>Substance Withdrawal Syndrome - physiopathology</topic><topic>Substance Withdrawal Syndrome - psychology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McNally, G.P</creatorcontrib><creatorcontrib>Akil, H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><jtitle>Neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McNally, G.P</au><au>Akil, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal</atitle><jtitle>Neuroscience</jtitle><addtitle>Neuroscience</addtitle><date>2002-01-01</date><risdate>2002</risdate><volume>112</volume><issue>3</issue><spage>605</spage><epage>617</epage><pages>605-617</pages><issn>0306-4522</issn><eissn>1873-7544</eissn><coden>NRSCDN</coden><abstract>The extra-hypothalamic actions of corticotropin-releasing hormone (CRH) have been accorded an important role in coordinating responses to stressors and contributing to the consequences of drug abuse. Recent proposals suggest that CRH actions in the bed nucleus of the stria terminalis coordinate responses to tonic/unpredictable stressors whereas these actions in the central nucleus of the amygdala coordinate responses to phasic/predictable stressors. We used
in situ hybridization histochemistry and site-specific microinjections of a CRH receptor antagonist to study the role of CRH in opiate withdrawal.
Rats undergoing opiate withdrawal displayed clear behavioral and autonomic changes accompanied by hyperalgesia and increased plasma corticosterone.
In situ hybridization of CRH mRNA revealed significant increases in the central nucleus of the amygdala but not in the bed nucleus of the stria terminalis among rats either chronically pre-treated with morphine, given an injection of naloxone, or both (precipitated withdrawal). An increase of CRH mRNA in the paraventricular nucleus of the hypothalamus was specific to rats undergoing withdrawal. Intracerebroventricular microinjection of the CRH receptor antagonist, αhCRH
9–41, reduced the severity of opiate withdrawal. Microinjections of αhCRH
9–41 into the central nucleus of the amygdala also reduced the severity of withdrawal whereas bed nucleus of the stria terminalis microinjections of αhCRH
9–41 were without effect.
These experiments provide evidence for a role of amygdala, but not bed nucleus of the stria terminalis, CRH in opiate dependence. We propose a specific role for down-regulation of opiate receptor signaling in increased expression of the CRH gene in the amygdala. Moreover, we suggest that the roles accorded to CRH in the bed nucleus of the stria terminalis versus amygdala in coordinating responses to stressors may need to be reconsidered to distinguish between external and internal/interoceptive stressors.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>12074902</pmid><doi>10.1016/S0306-4522(02)00105-7</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0306-4522 |
ispartof | Neuroscience, 2002-01, Vol.112 (3), p.605-617 |
issn | 0306-4522 1873-7544 |
language | eng |
recordid | cdi_proquest_miscellaneous_18473271 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Amygdala - physiopathology Animals anxiety Behavior, Animal - physiology Behavioral psychophysiology Biological and medical sciences Corticotropin-Releasing Hormone - administration & dosage Corticotropin-Releasing Hormone - genetics Corticotropin-Releasing Hormone - metabolism Corticotropin-Releasing Hormone - pharmacology drug dependence Endocrine Glands - physiopathology fear Fundamental and applied biological sciences. Psychology Hormones and behavior Humans hyperalgesia in situ hybridization Injections Injections, Intraventricular Male Morphine - adverse effects Naloxone - pharmacology Narcotic Antagonists - pharmacology Narcotics - adverse effects Pain - physiopathology Peptide Fragments - administration & dosage Peptide Fragments - pharmacology Psychology. Psychoanalysis. Psychiatry Psychology. Psychophysiology Rats Rats, Sprague-Dawley RNA, Messenger - metabolism Septal Nuclei - physiopathology stress Substance Withdrawal Syndrome - physiopathology Substance Withdrawal Syndrome - psychology |
title | Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T12%3A59%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20corticotropin-releasing%20hormone%20in%20the%20amygdala%20and%20bed%20nucleus%20of%20the%20stria%20terminalis%20in%20the%20behavioral,%20pain%20modulatory,%20and%20endocrine%20consequences%20of%20opiate%20withdrawal&rft.jtitle=Neuroscience&rft.au=McNally,%20G.P&rft.date=2002-01-01&rft.volume=112&rft.issue=3&rft.spage=605&rft.epage=617&rft.pages=605-617&rft.issn=0306-4522&rft.eissn=1873-7544&rft.coden=NRSCDN&rft_id=info:doi/10.1016/S0306-4522(02)00105-7&rft_dat=%3Cproquest_cross%3E18473271%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18473271&rft_id=info:pmid/12074902&rft_els_id=S0306452202001057&rfr_iscdi=true |